Intervention
Carbidopa
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 9 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownHistaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachNCT03266965 · 2018-03-23
COMPLETEDNorepinephrine-targeted Therapy for Action Control in Parkinson DiseaseNCT03115827 · 2017-04-18
COMPLETEDA Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With AsthmaNCT02633007 · 2015-12-01
COMPLETEDEfficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.NCT01227655 · 2011-03-01
COMPLETEDEfficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" PhenomenonNCT01568073 · 2011-03-01
COMPLETEDComparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensNCT01296464 · 2011-02-01
COMPLETEDA Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease PatientsNCT01229332 · 2011-01-01
COMPLETEDAcute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)NCT00845000 · 2009-04-21
COMPLETEDAugmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED8
TERMINATED1
Phase mix
PHASE15
PHASE23
PHASE32
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.